Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 50 of 361 entries
View as:

A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00491530 Org: User:
Start: 06/30/07 End: 11/30/08 Due: 11/30/09

Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT01114880 Org: User:
Start: 01/31/10 End: 02/28/11 Due: 02/28/12

Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children

Phase: N/A Priority: Normal
NCT ID: NCT00585481 Org: User:
Start: 01/31/08 End: 12/31/10 Due: 12/31/11

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00061659 Org: User:
Start: 05/31/03 End: 04/30/06 Due: 04/30/07

Recovery Time in Children With Lower Respiratory Tract Infections Treated With Klacid® Granules for Oral Suspension.

Phase: N/A Priority: Normal
NCT ID: NCT01076166 Org: User:
Start: 04/30/09 End: 01/31/10 Due: 01/31/11

Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00053547 Org: User:
Start: 01/31/02 End: - Due: -

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00237887 Org: User:
Start: 12/31/04 End: - Due: -

A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00391729 Org: User:
Start: 10/31/06 End: 06/30/07 Due: 06/30/08

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)

Phase: N/A Priority: Normal
NCT ID: NCT00478660 Org: User:
Start: 02/28/06 End: - Due: -

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00195676 Org: User:
Start: 05/31/04 End: 10/31/09 Due: 10/31/10

A Safety and Tolerability Study of ABT-126 in Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00867399 Org: User:
Start: 03/31/09 End: - Due: -

Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT03473561 Org: User:
Start: 08/25/18 End: 01/08/20 Due: 01/08/21

Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)

Phase: N/A Priority: Normal
NCT ID: NCT00701805 Org: User:
Start: 07/31/08 End: 12/31/09 Due: 12/31/10

Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT01525563 Org: User:
Start: 04/30/12 End: 12/31/13 Due: 12/31/14

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00073151 Org: User:
Start: 09/30/03 End: 01/31/06 Due: 01/31/07

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00402584 Org: User:
Start: 08/31/00 End: - Due: -

Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01027260 Org: User:
Start: 06/30/08 End: 09/30/10 Due: 09/30/11

A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00666692 Org: User:
Start: 04/30/08 End: 10/31/08 Due: 10/31/09

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

Phase: N/A Priority: Normal
NCT ID: NCT01124851 Org: User:
Start: 08/31/10 End: 04/30/11 Due: 04/30/12

An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00060905 Org: User:
Start: 01/31/03 End: - Due: -

A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

Phase: N/A Priority: Normal
NCT ID: NCT00427362 Org: User:
Start: 05/31/06 End: - Due: -

An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02298556 Org: User:
Start: 10/31/14 End: 03/08/16 Due: 03/08/17

Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine

Phase: N/A Priority: Normal
NCT ID: NCT01078610 Org: User:
Start: - End: - Due: -

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00038636 Org: User:
Start: 09/30/00 End: - Due: -

Phase 1 BA Study, Single Center With Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00870948 Org: User:
Start: 01/31/09 End: - Due: -